Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors

被引：1
|
作者：
Roschewski, Mark [1 ]
Dunleavy, Kieron [1 ]
机构：
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 06期
关键词：
OCCULT LEPTOMENINGEAL DISEASE; NON-HODGKINS-LYMPHOMA; DOUBLE-HIT LYMPHOMA; RISK-FACTORS; ELDERLY-PATIENTS; RITUXIMAB; RELAPSE; INVOLVEMENT; PROPHYLAXIS; RECURRENCE;
D O I：
10.3109/10428194.2015.1016936
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1583 / 1584
页数：2
相关论文
共 50 条
  • [1] Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?
    Korfel, Agnieszka
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 436 - 440
  • [2] Central nervous system prophylaxis in diffuse large B-cell lymphoma
    Zahid, Mohammad Faizan
    Khan, Nadia
    Hashmi, Shahrukh K.
    Kizilbash, Sani Haider
    Barta, Stefan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (02) : 108 - 120
  • [3] Central nervous system involvement in diffuse large B-cell lymphoma
    Yamamoto, Wataru
    Tomita, Naoto
    Watanabe, Reina
    Hattori, Yukako
    Nakajima, Yuki
    Hyo, Rie
    Hashimoto, Chizuko
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (01) : 6 - 10
  • [4] Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma
    Kim, Seok Jin
    Oh, Sung Yong
    Kim, Jin Seok
    Kim, Hawk
    Lee, Gyeong-Won
    Won, Jong Ho
    Shin, Ho Jin
    Yang, Deok Hwan
    Choi, Chul Won
    Park, Jinny
    Kim, Won Seog
    Suh, Cheolwon
    ANNALS OF HEMATOLOGY, 2011, 90 (05) : 539 - 546
  • [5] Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
    Tomita, Naoto
    Yokoyama, Masahiro
    Yamamoto, Wataru
    Watanabe, Reina
    Shimazu, Yutaka
    Masaki, Yasufumi
    Tsunoda, Saburo
    Hashimoto, Chizuko
    Murayama, Kayoko
    Yano, Takahiro
    Okamoto, Rumiko
    Kikuchi, Ako
    Tamura, Kazuo
    Sato, Kazuya
    Sunami, Kazutaka
    Shibayama, Hirohiko
    Takimoto, Rishu
    Ohshima, Rika
    Hatta, Yoshihiro
    Moriuchi, Yukiyoshi
    Kinoshita, Tomohiro
    Yamamoto, Masahide
    Numata, Ayumi
    Ishigatsubo, Yoshiaki
    Takeuchi, Kengo
    CANCER SCIENCE, 2012, 103 (02) : 245 - 251
  • [6] Central nervous system relapse in diffuse large B cell lymphoma: Risk factors
    Sancho, Juan-Manuel
    Ribera, Josep-Maria
    MEDICINA CLINICA, 2016, 146 (02): : 74 - 80
  • [7] Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?
    Cheah, Chan Y.
    Seymour, John F.
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 471 - 473
  • [8] Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era
    Fletcher, Christopher D.
    Kahl, Brad S.
    LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2228 - 2240
  • [9] The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
    Mitrovic, Zdravko
    Bast, Martin
    Bierman, Philip J.
    Bociek, Robert G.
    Vose, Julie M.
    Chan, Wing C.
    Armitage, James O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (03) : 401 - 403
  • [10] Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma
    Garwood, Melissa J.
    Hawkes, Eliza A.
    Churilov, Leonid
    Chong, Geoffrey
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 133 - 140
12345